Possible new treatment for MS on the horizonPublished: 30 June 2021 A new less expensive, more convenient treatment for multiple sclerosis (MS) could be on the horizon.  Ublituximad, made by TG Therapeutics, has been shown to significantly reduce the annualised relapse rate in people with relapsing MS when compared with